Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
European Journal of Clinical Investigation|February 13, 2025
Adverse events and impact on quality of life of antibody-drug conjugates in the treatment of metastatic breast cancer: A systematic review and meta-analysisMarta Perachino, Eva Blondeaux, Chiara Molinelli, et al.
Breast (Edinburgh, Scotland)|May 7, 2025
Physicians' knowledge, practice, and attitudes on fertility and pregnancy-related issues in young women with advanced breast cancer: results of the ABC6 and ABC7 surveySimone Nardin, Luca Arecco, Virginia Delucchi, et al.
Cancers|April 23, 2022
Definition of High-Risk Early Hormone-Positive HER2-Negative Breast Cancer: A Consensus ReviewMattia Garutti, Gaia Griguolo, Andrea Botticelli, et al.
European Journal of Cancer (Oxford, England : 1990)|February 6, 2026
Comparison of suboptimal versus adequate ovarian function suppression in premenopausal women with early breast cancer treated with adjuvant endocrine therapy: An exploratory analysis of two prospective studiesSimone Nardin, Marco Bruzzone, Luca Arecco, et al.
Frontiers in Immunology|June 5, 2026
Long-term immune response to mRNA anti-SARS-CoV-2 vaccination in patients with cancerSoraia Lobo-Martins, Diogo Martins-Branco, Francine Padonou, et al.
Clinical Breast Cancer|June 7, 2025
Real-World 5-Year Outcomes of Patients Treated With the Adjuvant Paclitaxel Trastuzumab (APT) Regimen for Stage I HER2-Positive Early Breast Cancer: A Retrospective International StudySoraia Lobo-Martins, Veronique Debien, Elisa Agostinetto, et al.
Breast (Edinburgh, Scotland)|October 18, 2025
The role of body mass index at diagnosis in patients with inflammatory breast cancerKristien Borremans, Ha-Linh Nguyen, Maxim De Schepper, et al.
Cancer Research Communications|December 26, 2023
Treatment Response, Tumor Infiltrating Lymphocytes and Clinical Outcomes in Inflammatory Breast Cancer-Treated with Neoadjuvant Systemic TherapyMaxim De Schepper, Ha-Linh Nguyen, François Richard, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 31, 2021
Impact of Baseline and On-Treatment Glycemia on Everolimus-Exemestane Efficacy in Patients with Hormone Receptor-Positive Advanced Breast Cancer (EVERMET)Claudio Vernieri, Federico Nichetti, Luca Lalli, et al.
Cancer|May 16, 2024
Characterization of HER2-low breast cancer in young women with germline BRCA1/2 pathogenetic variants: Results of a large international retrospective cohort studyFrancesco Schettini, Eva Blondeaux, Chiara Molinelli, et al.
Pageof 3